Boron, strength and body composition during training
A boron tablet study in trained bodybuilders.
Key points
- In trained bodybuilders aged 20–27, a boron tablet did not provide additional gains in squat and bench-press strength compared with placebo over seven weeks. This study does not confirm a strength gain from this regimen. [1] See the evidence 1
- In the bodybuilder study, no additional lean mass gain compared with placebo was found. These data do not support expecting a confirmed mass gain from the tablet studied. [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Strength and lean mass were assessed separately.
Key points
Why these conclusions
Seven-week study
Bodybuilders aged 20–27 with at least one year’s training experience took a boron tablet or placebo for 49 days while training four days per week. The tablet contained a measured 2.49 ± 0.12 mg elemental boron versus 5 mg on the label; the chemical form was not established. No additional gain in strength or lean mass compared with placebo was found. [1]
Excess boron can cause nausea, vomiting, diarrhea and severe poisoning. Upper levels for long-term total intake in adults: EFSA 10 mg/day; United States for people aged 19 and older 20 mg/day; these are neither supplement doses nor thresholds guaranteeing harm. [2] [3]
No additional gain in squat and bench-press strength compared with placebo was found.
| Parameter | Data |
|---|---|
| Result | No additional gain in squat and bench-press strength compared with placebo was found. Both exercises improved over time; no additional boron effect was found. Complete data were available for 9 versus 6 participants for squat and 9 versus 9 for bench press. |
| Participants | 19 bodybuilders aged 20–27 with at least one year’s training experience, training four days per week |
| Form | Tablet, chemical form not established |
| Dose | Measured 2.49 ± 0.12 mg elemental boron per tablet per day; label stated 5 mg |
| Dose basis | Measured 2.49 ± 0.12 mg elemental boron per tablet per day; label stated 5 mg |
| Comparator | Milk-protein placebo tablet containing 0.002 ± 0.001 mg boron; training in both groups |
| Duration | 49 days, or 7 weeks |
| Confidence | 1/4: Precision: very serious limitation: groups of at most 10 and 9 people; no usable CI for the difference in changes, so substantial benefit or harm cannot be ruled out.; Consistency: one independent trial; the 1994 publication concerns the same group, so consistency between trials cannot be assessed.; Applicability: directly concerns the specified group, intervention and outcome; no transfer beyond them is intended.; Possible publication bias: insufficient data to establish publication bias in one small evidence base; no separate downgrade.; Study methods: serious limitation: randomization and double blinding were stated but sequence and allocation concealment are unclear; baseline training differed and complete-case analysis after injuries further limits strength assessment, especially squat. |
| Evidence base | 1 trial |
| Sources | [1] |
No additional lean mass gain compared with placebo was found.
| Parameter | Data |
|---|---|
| Result | No additional lean mass gain compared with placebo was found. Lean mass increased during training without a significant additional effect of boron. |
| Participants | 19 bodybuilders aged 20–27 with at least one year’s training experience, training four days per week |
| Form | Tablet, chemical form not established |
| Dose | Measured 2.49 ± 0.12 mg elemental boron per tablet per day; label stated 5 mg |
| Dose basis | Measured 2.49 ± 0.12 mg elemental boron per tablet per day; label stated 5 mg |
| Comparator | Milk-protein placebo tablet containing 0.002 ± 0.001 mg boron; training in both groups |
| Duration | 49 days, or 7 weeks |
| Confidence | 1/4: Precision: very serious limitation: groups of at most 10 and 9 people; no usable CI for the difference in changes, so substantial benefit or harm cannot be ruled out.; Consistency: one independent trial; the 1994 publication concerns the same group, so consistency between trials cannot be assessed.; Applicability: directly concerns the specified group, intervention and outcome; no transfer beyond them is intended.; Possible publication bias: insufficient data to establish publication bias in one small evidence base; no separate downgrade.; Study methods: serious limitation: randomization and double blinding were stated but sequence and allocation concealment are unclear; baseline training and diet differed, potentially affecting lean mass change. |
| Evidence base | 1 trial |
| Sources | [1] |
Excess boron can cause nausea, vomiting, diarrhea and severe poisoning. Upper levels for long-term total intake in adults: EFSA 10 mg/day; United States for people aged 19 and older 20 mg/day; these are neither supplement doses nor thresholds guaranteeing harm.
Excess boron can cause nausea, vomiting, diarrhea and severe poisoning. Upper levels for long-term total intake in adults: EFSA 10 mg/day; United States for people aged 19 and older 20 mg/day; these are neither supplement doses nor thresholds guaranteeing harm. [2] [3]
More details
What was compared
Strength and lean mass changed during training; the comparison showed no additional effect of the tablet studied. [1]
Sources
- The effect of boron supplementation on lean body mass, plasma testosterone levels, and strength in male bodybuilders. https://pubmed.ncbi.nlm.nih.gov/8508192/
- Boron - Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Boron-HealthProfessional/
- Summary of Tolerable Upper Intake Levels for minerals. https://www.efsa.europa.eu/sites/default/files/2023-11/ul_summary_tables-version-8.pdf
Methodology: Subpages evidence-led supplement pipeline v1